CHEMISTS' OWN LACTULOSE 667 mg/mL oral liquid bottle

Country: Ավստրալիա

language: անգլերեն

source: Department of Health (Therapeutic Goods Administration)

active_ingredient:

lactulose, Quantity: 667 mg/mL

MAH:

Arrotex Pharmaceuticals Pty Ltd

INN:

Lactulose

pharmaceutical_form:

Oral Liquid

composition:

Excipient Ingredients:

administration_route:

Oral

units_in_package:

500 mL

prescription_type:

Not scheduled. Not considered by committee

therapeutic_indication:

Treatment of acute, and prevention and treatment of chronic portal-systemic encephalopathy (PSE), including the stages of hepatic pre-coma and coma.,Treatment of chronic and habitual constipation.,Where a soft stool is considered of medical benefit (haemorrhoids, post-colonic/anal surgery).

leaflet_short:

Visual Identification: Clear, colourless to brownish-yellow, viscous liquid.; Container Type: Bottle; Container Material: Polyethylene Terephthalate; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

authorization_status:

Licence status A

authorization_date:

2014-02-13